Linea Directa 200 LEFT COL CAR INSURANCE

PROPERTY SEARCH

DomusVi Ciudad de Murcia residential cross content 1200

Date Published: 10/02/2022

ARCHIVED - Novavax vaccine will be manufactured in Spain for whole of Europe

ARCHIVED ARTICLE

The Public Health Commission gives the go-ahead for the new US serum to be produced in Spain

<span style='color:#780948'>ARCHIVED</span> - Novavax vaccine will be manufactured in Spain for whole of Europe

The Public Health Commission has agreed the use of the Novavax vaccine for people who have not yet been fully immunised or who have allergies to any of the components of the other four vaccines on the market.

And the vaccine will be manufactured in Spain for the whole of the European Union following an agreement by the body made up of general directors of public health within the Ministry of Health.

But what is new about the Novavax vaccine and how does it work?

Novavax is the first protein-based vaccine against Covid and, unlike Pfizer and Moderna (which are messenger RNA vaccines) and AstraZeneca and Janssen (which are adenovirus vaccines), it has distinctive advantages.

The main advtantage is that it does not require special cold storage conditions and with a small refrigerator, the doses can be transported in a perfect state of preservation.

In addition, Novavax does not introduce a genetic code into human cells so that they respond by generating the virus protein.

Also read: EU backs Novavax vaccine

Instead, it directly injects a purified version of a virus protein, and when the immune system recognises it as a foreign agent, it produces natural defences: antibodies and T-cells.

From that point on, should someone injected with Novavax become infected with SARS-CoV-2, the immune system will recognise the protein and respond to the infection in the same way other vaccines do.

Also of interest: Spain buys 2.2 million Novavax vaccines as third dose of Covid jab is anticipated

The vaccine, of US origin, will be produced in Spain for the European Union by the biopharmaceutical group Zendal, through its subsidiary Biofabri, based in Porriño, Pontevedra).

Who will get the new vaccine?

During the meeting of the general directors, it was agreed Novavax will be administered to people over 18 years of age who have not yet been immunised, with severe immunosuppression, people with allergies to various components in other atlernatives, and those who are at very high risk of severe complications following SARS-CoV-2 infection.

In addition, the Public Health Commission has updated the vaccination strategy by adding the already agreed recommendations on vaccination intervals after recovery from infection.

You might like: How to book a Covid vaccine in Spain and How to get a Covid passport in Spain

Image:

Linea Directa Bottom Article M-Z CAR INSURANCE

Read more about Coronavirus:

Sign up for the Spanish News Today Editors Roundup Weekly Bulletin to get a comprehensive email with all the week’s news for Spain, Murcia, Alicante and Andalucía.

Get a sneak peek – here are a few of our recent Subscription Bulletins: